NEWS & UPDATES
While medicines and vaccines are studied in well controlled clinical trials and reviewed by regulatory authorities with the aim of ensuring benefits outweigh risks, some adverse effects are observed only once the product is authorized by regulators and used by a larger population in real world conditions. It is therefore essential that medical products continue to be monitored for their effectiveness and safety post release.

MEDICAL PRODUCT ALERT NO. 1/2025: FALSIFIED (CONTAMINATED) OXYCONTIN 80MG TABLETS IDENTIFIED IN THE WHO EUROPEAN REGION
Finalised_WHO Alert No 1_Falsified Oxycontin Tablets_19032025Download

MEDICAL PRODUCT ALERT: RECALL OF METHYLATED SPIRIT
ZAMRA ALERT_Recall_Methylated Spirit_25112024Download

MEDICAL PRODUCT ALERT NO. 3/2024: FALSIFIED (CONTAMINATED) OXYMORPHONE HYDROCHLORIDE 40MG TABLETS IDENTIFIED IN THE WHO REGION FOR EUROPE
ZAMRA Medical_Product_Alert_3_2024Download